← Back to Search

Radiation Therapy

Radiotherapy for Keloids

Phase < 1
Recruiting
Research Sponsored by Albert Einstein College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinically diagnosed keloid
Surgical excision of keloid is either contraindicated or patient has declined treatment with surgical excision
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will study if radiation therapy is a safe and effective treatment for keloids that cannot be removed by surgery. The study will measure if the keloids shrink or stop growing, if symptoms improve, and if quality of life gets better.

Who is the study for?
This trial is for adults with clinically diagnosed keloids where surgery isn't an option or has been declined. It's open to those who have had keloids return after resection, as long as the current one can't be removed or they choose not to have it surgically treated. Women must test negative for pregnancy and agree to use contraception.Check my eligibility
What is being tested?
The study is testing the safety and effectiveness of radiation therapy on keloids that haven’t been removed by surgery. The main goal is to check for any side effects within 10 weeks, while also looking at whether the keloid stops growing, shrinks, feels better symptomatically, and improves life quality.See study design
What are the potential side effects?
Potential side effects from radiation therapy may include skin irritation, changes in skin coloration, fatigue, localized hair loss around the treatment area, and a slight risk of secondary cancers due to exposure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a keloid.
Select...
Surgery for my keloid is not an option or I have chosen not to have it.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Toxicity of the radiation
Secondary outcome measures
Size of keloids

Trial Design

1Treatment groups
Experimental Treatment
Group I: Radiation therapy groupExperimental Treatment1 Intervention
Single-institution pilot study to evaluate the safety and efficacy of radiation therapy (RT) for the treatment of unresected keloids. The primary endpoint will be toxicity within 10 weeks of follow-up. Secondary endpoints will include cessation of growth or shrinkage of keloids, symptomatic response, and impact on quality of life.

Find a Location

Who is running the clinical trial?

Albert Einstein College of MedicineLead Sponsor
285 Previous Clinical Trials
11,856,504 Total Patients Enrolled

Media Library

Radiation therapy of unresected keloids (Radiation Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT04853433 — Phase < 1
Radiation Therapy for the Treatment of Keloids Research Study Groups: Radiation therapy group
Radiation Therapy for the Treatment of Keloids Clinical Trial 2023: Radiation therapy of unresected keloids Highlights & Side Effects. Trial Name: NCT04853433 — Phase < 1
Radiation therapy of unresected keloids (Radiation Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04853433 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitments for this trial still open?

"This clinical trial is currently open to applicants, with the original posting date being December 1st 2020 and further updates occurring on November 11th 2022 according to records located at clinicaltrials.gov."

Answered by AI

What is the current enrolment for this clinical research?

"Affirmative. As per information made available on clinicaltrials.gov, this medical trial is actively recruiting participants and was initially posted in December 2020 with the latest update occurring November 2022. 15 patients are required from a single site for the study to move forward."

Answered by AI

Who else is applying?

What site did they apply to?
Albert Einstein College of Medicine
What portion of applicants met pre-screening criteria?
Did not meet criteria
~2 spots leftby Dec 2024